Phase 2 trials indicate MDMA safe and effective

Results from Phase 2 clinical trials indicate MDMA-assisted psychotherapy for PTSD is safe and effective.

The researchers pooled data from six Phase 2 clinical trials that were carried out from 2004 to 2017 to examine the outcomes of MDMA-assisted psychotherapy for PTSD.

The researchers found that the treatment appeared to be both safe and effective. After two experimental sessions, approximately 50% of participants who received active doses of MDMA no longer met PTSD diagnostic criteria, compared to 23% of participants who received placebo.